Stock of the Day
Incyte (NASDAQ:INCY)
Market Capitalization
$20.16BP/E Ratio
17.20Price Target
$99.07About Incyte
Incyte Corporation is a Wilmington, Delaware–based biopharmaceutical company focused on the discovery, development and commercialization of novel therapies in oncology and inflammation. Since its founding in 2002, Incyte has grown from a small research organization into a global enterprise, advancing a portfolio of internally developed and partnered assets. The company's research and development efforts center on small-molecule drugs and biologics that modulate critical signaling pathways implicated in cancer, autoimmune disorders and rare diseases. The company's flagship product is Jakafi®... Read Full Profile ▷
INCY Company Calendar
| Next Earnings (Estimated) |
|
Recent Incyte News
Top Stock News for Friday, December 19th
For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allows you to protect your retirement savings before billions in American wealth are lost.
Download Your Free 2026 Wealth Protection Guide and execute the simple steps to protect your future.
GET THE FREE GUIDE ▷ Apparel behemoth Nike just released its latest earnings as the firm works to revamp its business. Should investors buy in or look elsewhere for opportunities?
Read The Full Story ▷ Looking for AI stocks with staying power—or a hedge if the bubble bursts? Discover two dividend-paying companies built for both 2026 outcomes.
Read The Full Story ▷ While headlines focus on Tesla's car sales, tech analyst Jeff Brown says the real story is Tesla's role in a $25 trillion AI revolution — one that Nvidia's CEO himself has called a "multi-trillion-dollar future industry" — and he's uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough.
Click here now to see the full report ▷ ETFs with focuses on small-cap stocks, companies doing business in space, lithium, and options strategies could all be in for continued gains in 2026.
Read The Full Story ▷ President Trump's new executive order on AI looks like a step in the right direction for Big Tech. One analyst calls it a "major win" for companies like META.
Read The Full Story ▷ Elon Musk's Starlink project is generating major speculation ahead of a potential IPO that some analysts believe could reach a historic $100 billion valuation. According to James Altucher, there may be a smart "backdoor" way for everyday investors to position ahead of that event without needing traditional IPO access — and he says it can be done for under $100. He's also sharing a free ticker tied to this trend for anyone who wants to take a closer look.
Click here to learn more ▷ Reddit has had a banner year in 2025, with highlights including significant improvement to revenue and a widening user base. Will it continue in the new year?
Read The Full Story ▷ 
